Differential expression of liver fluke β-tubulin isotypes at selected life cycle stages

International Journal for Parasitology

Volumn 43, Issue 14, 2013, Pages 1133-1139

  Fuchs, Marc Aurel ^a   Ryan, Louise A ^a   Chambers, Emma L ^a   Moore, Catherine M ^a   Fairweather, Ian ^a   Trudgett, Alan ^a   Timson, David J ^a   Brennan, Gerry P ^a   Hoey, Elizabeth M ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Anthelmintic resistance; Fasciola hepatica; Microtubule; Tubulin isotype

Indexed keywords

BENZIMIDAZOLE; BETA TUBULIN; TRICLABENDAZOLE;

AMINO ACID; DRUG RESISTANCE; FLATWORM; LIFE CYCLE; PARASITE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS;

ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; FASCIOLA HEPATICA; HOMOZYGOSITY; IMMUNOLOCALIZATION; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; SPERMATOZOON MATURATION; TREMATODE LIFE CYCLE STAGE; VITELLINE MEMBRANE;

FASCIOLA HEPATICA;

ANTHELMINTIC RESISTANCE; FASCIOLA HEPATICA; MICROTUBULE; TUBULIN ISOTYPE;

ANIMALS; ANTHELMINTICS; BENZIMIDAZOLES; DRUG RESISTANCE; FASCIOLA HEPATICA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LIFE CYCLE STAGES; PROTEIN ISOFORMS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TUBULIN;

EID: 84888428615     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2013.08.007     Document Type: Article

References (43)

1. Alvarez L.I., Solana H.D., Mottier M.L., Virkel G.L., Fairweather I., Lanusse C.E. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes. Parasitology 2005, 131:501-510.
2. Canevari J., Ceballos L., Sanabria R., Romero J., Olaechea F., Ortiz P., Cabrera M., Gayo V., Fairweather I., Lanusse C., Alvarez L. Testing albendazole resistance in Fasciola hepatica: validation of an egg hatch test with isolates from South America and the United Kingdom. J. Helminthol. 2013, 19:1-7. 10.1017/S0022149X13000163.
3. Chambers E., Ryan L.A., Hoey E.M., Trudgett A., McFerran N.V., Fairweather I., Timson D.J. Liver fluke beta-tubulin isotype 2 binds albendazole and is thus a probable target of this drug. Parasitol. Res. 2010, 107:1257-1264.
4. Chemale G., Perally S., LaCourse E.J., Prescott M.C., Jones L.M., Ward D., Meaney M., Hoey E., Brennan G.P., Fairweather I., Trudgett A., Brophy P.M. Comparative proteomic analysis of triclabendazole response in the liver fluke Fasciola hepatica. J. Proteome Res. 2010, 9:4940-4951.
5. Devine C., Brennan G.P., Lanusse C.E., Alvarez L.I., Trudgett A., Hoey E., Fairweather I. Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica. Parasitology 2009, 136:183-192.
6. Devine C., Brennan G.P., Lanusse C.E., Alvarez L.I., Trudgett A., Hoey E., Fairweather I. Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica. Parasitology 2011, 138:224-236.
7. Downing K.H., Nogales E. Tubulin structure: insights into microtubule properties and functions. Curr. Opin. Struct. Biol. 1998, 8:785-791.
8. Fairweather I. Triclabendazole: new skills to unravel an old(ish) enigma. J. Helminthol. 2005, 79:227-234.
9. Fairweather I. Liver fluke isolates: a question of provenance. Vet. Parasitol. 2011, 176:1-8.
10. Fairweather I., Boray J.C. Fasciolicide action. Fasciolosis 1999, 225-276. CAB international Publishing, Wallingford. J. Dalton (Ed.).
11. Fletcher H.L., Hoey E.M., Orr N., Trudgett A., Fairweather I., Robinson M.W. The occurrence and significance of triploidy in the liver fluke, Fasciola hepatica. Parasitology 2004, 128:69-72.
12. Fulton C., Simpson P.A. Selective synthesis and utilization of flagellar tubulin the multitubulin hypothesis. Cell Motility 1976, 987-1005. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. R. Goldman, T. Pollard, J. Rosenhaum (Eds.).
13. Gilleard J.S. Understanding anthelmintic resistance: the need for genomics and genetics. Int. J. Parasitol. 2006, 36:1227-1239.
14. Hanna R.E., Edgar H.W., McConnell S., Toner E., McConville M., Brennan G.P., Devine C., Flanagan A., Halferty L., Meaney M., Shaw L., Moffett D., McCoy M., Fairweather I. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha. Vet. Parasitol. 2010, 20(168):240-254.
15. Hurd D.D., Miller R.M., Núñez L., Portman D.S. Specific alpha- and beta-tubulin isotypes optimize the functions of sensory Cilia in Caenorhabditis elegans. Genetics 2010, 185:883-896.
16. Joe P.A., Banerjee A., Ludueña R.F. Roles of beta-tubulin residues Ala428 and Thr429 in microtubule formation in vivo. J. Biol. Chem. 2009, 284:4283-4291.
17. Joshi H.C., Cleveland D.W. Diversity among tubulin subunits: toward what functional end?. Cell Motil. Cytoskeleton 1990, 16:159-163.
18. Kelley L.A., Sternberg M.J.E. Protein structure prediction on the web: a case study using the Phyre server. Nat. Protoc. 2009, 4:363-371.
19. Kikkawa M., Hirokawa N. High-resolution cryo-EM maps show the nucleotide binding pocket of KIF1A in open and closed conformations. EMBO J. 2006, 25:4187-4194.
20. Krieger E., Joo K., Lee J., Lee J., Raman S., Thompson J., Tyka M., Baker D., Karplus K. Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins 2009, 77(Suppl. 9):114-122.
21. Kwa M.S., Kooyman F.N., Boersema J.H., Roos M.H. Effect of selection for benzimidazole resistance in Haemonchus contortus on beta-tubulin isotype 1 and isotype 2 genes. Biochem. Biophys. Res. Commun. 1993, 191:413-419.
22. Kwa M.S., Veenstra J.G., Roos M.H. Molecular characterisation of beta-tubulin genes present in benzimidazole-resistant populations of Haemonchus contortus. Mol. Biochem. Parasitol. 1993, 60:133-143.
23. Kwa M.S., Veenstra J.G., Roos M.H. Benzimidazole resistance in Haemonchus contortus is correlated with a conserved mutation at amino acid 200 in beta-tubulin isotype1. Mol. Biochem. Parasitol. 1994, 63:299-303.
24. Li S., Hong S.J., Choi M.H., Hong S.T. Identification of two beta-tubulin isotypes of Clonorchis sinensis. Parasitol. Res. 2009, 105:1015-1021.
25. Löwe J., Li H., Downing K.H., Nogales E. Refined structure of alpha beta-tubulin at 3.5A resolution. J. Mol. Biol. 2001, 313:1045-1057.
26. Ludueña R.F. Are tubulin isotypes functionally significant?. Mol. Biol. Cell 1993, 4:445-457.
27. McGonigle L., Mousley A., Marks N.J., Brennan G.P., Dalton J.P., Spithill T.W., Day T.A., Maule A.G. The silencing of cysteine proteases in Fasciola hepatica newly-excysted juveniles using RNA interference reduces gut penetration. Int. J. Parasitol. 2008, 38:149-155.
28. Meaney M., Fairweather I., Brennan G.P., McDowell L.S., Forbes A.B. Fasciola hepatica: effects of the fasciolicide clorsulon in vitro and in vivo on the tegumental surface, and a comparison of the effects on young- and old-mature flukes. Parasitol. Res. 2003, 91:238-250.
29. Mottier L., Alvarez L., Fairweather I., Lanusse C. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect. J. Parasitol. 2006, 92:1355-1360.
30. Nogales E., Wolf S.G., Downing K.H. Structure of the alpha beta tubulin dimer by electron crystallography. Nature 1998, 391:199-203.
31. Raff E.C., Fackenthal J.D., Hutchens J.A., Hoyle H.D., Turner F.R. Microtubule architecture specified by a beta-tubulin isoform. Science 1997, 275:70-73.
32. Rinaldi G., Morales M.E., Cancela M., Castillo E., Brindley P.J., Tort J.F. Development of functional genomic tools in trematodes: RNA interference and luciferase reporter gene activity in Fasciola hepatica. PLoS. Negl. Trop. Dis. 2008, 27:e260.
33. Robinson M.W., Trudgett A., Hoey E.M., Hoey I. Triclabendazole-resistant Fasciola hepatica: beta-tubulin and response to in vitro treatment with triclabendazole. Parasitology 2002, 124:325-338.
34. Robinson M.W., Lawson J., Trudgett A., Hoey E.M., Fairweather I. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitol. Res. 2004, 92:205-210.
35. Robinson M.W., McFerran N., Trudgett A., Hoey L., Fairweather I. A possible model of benzimidazole binding to β-tubulin disclosed by invoking an inter-domain movement. J. Mol. Graph. Model. 2004, 23:275-284.
36. Rowcliffe S.A., Ollerenshaw C.B. Observations on the bionomics of the egg of Fasciola hepatica. Ann. Trop. Med. Parasitol. 1960, 54:172-181.
37. Ryan L.A., Hoey E., Trudgett A., Fairweather I., Fuchs M., Robinson M.W., Chambers E., Timson D.J., Ryan E., Fetwell T., Ivens A., Bentley G., Johnston D. Fasciola hepatica expresses multiple α- and β-tubulin isotypes. Mol. Biochem. Parasitol. 2008, 159:73-78.
38. Sanabria R., Ceballos L., Moreno L., Romero J., Lanusse C., Alvarez L. Identification of a field isolate of Fasciola hepatica resistant to albendazole and susceptible to triclabendazole. Vet. Parasitol. 2013, 193:105-110.
39. Savage C., Hamelin M., Culotti J.G., Coulson A., Albertson D.G., Chalfie M. mec-7 is a beta-tubulin gene required for the production of 15-protofilament microtubules in Caenorhabditis elegans. Genes Dev. 1989, 3:870-881.
40. Trudgett A., Anderson A., Hanna R.E. Use of immunosorbent-purified antigens of Fasciola hepatica in enzyme immunoassays. Res. Vet. Sci. 1988, 44:262-263.
41. Von Samson-Himmelstjerna G., Blackhall W.J., McCarthy J.S., Skuce P.J. Single nucleotide polymorphism (SNP) markers for benzimidazole resistance in veterinary nematodes. Parasitology 2007, 134:1077-1086.
42. Wallin M., Stromberg E. Cold-stable and cold-adapted microtubules. Int. Rev. Cytol. 1995, 157:1-31.
43. Wright A.J., Hunter C.P. Mutations in a beta-tubulin disrupt spindle orientation and microtubule dynamics in the early Caenorhabditis elegans embryo. Mol. Biol. Cell 2003, 11:4512-4525.